NEKTAR THERAPEUTICS : Entry into a Material Definitive Agreement (form 8-K)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): January 9, 2020

 

NEKTAR THERAPEUTICS

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

0-24006

 

94-3134940

(State or Other Jurisdiction
of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

455 Mission Bay Boulevard South
San Francisco, California94158

(Address of Principal Executive Offices and Zip Code)

 

Registrant’s telephone number, including
area code: [phone]

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Share

© Acquiremedia - 2020